Skip to content

The Archive · A Source

Orphan-Drug Pricing in EU5: Germany-First Launch Strategy for Neuromuscular Diseases

Vasro 2024 vasro.de/en/orphan-drug-pricing-eu5-germany-first-launch-strategy-for-neuromuscular